Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. Jerry Klauer, an Alzheimer's patient who received a ...

The FDA recently cleared the Lumipulse blood test for early diagnosis of Alzheimer's disease in people 55 and over with memory loss. The noninvasive Lumipulse blood test measures the levels of two ...

In May 2025, the U.S. Food and Drug Administration cleared the first blood-based in vitro diagnostic test for AD, ...

Findings suggest the test can reduce the need for PET imaging in some patients with mild cognitive decline to enable therapeutic focus on non-Alzheimer's disease causes, broadening access to quality ...

Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related to Alzheimer's disease in individuals with mild cognitive impairment (MCI) ...

Panelists discuss how managed care organizations can improve Alzheimer diagnostic test access while navigating complex coverage challenges for amyloid-targeting therapies across traditional Medicare ...

The first drugs against Alzheimer's disease that are intended to slow down the progression of the condition will soon be authorized in Germany. On November 14, 2024, the EMA granted approval for ...

With nearly seven million Americans currently living with Alzheimer’s disease — and 13 million projected to have the illness by 2050 — early diagnosis and treatment are more urgent than ever. To help ...

Researchers at Northwestern University have identified a specific step inside brain synapses where the toxic Alzheimer’s ...

Reddy is a health policy fellow and neurologist at the University of California, San Francisco. Yaffe is the vice chair of psychiatry, neurology, and epidemiology at UCSF and the director of the ...

ST. LOUIS--(BUSINESS WIRE)--New research finds that C₂N Diagnostics, LLC’s proprietary algorithm used in its PrecivityAD2 blood test, which is used by healthcare providers to determine Alzheimer’s ...

A research group has investigated how Alzheimer's disease can be diagnosed more reliably in the future. A research group at LMU University Hospital has investigated how Alzheimer's disease can be ...